Skip to main content
SNO 28th Annual Meeting Main banner
Final Program


Program
Icon Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
ISS CME
ISS CME
Named Award Winner
Named Award Winner
Award Winner
Award Winner
Poster Award Winner
Poster Award Winner

Randy Schrecengost

Targepeutics
Hershey, Pennsylvania, United States

Dr Randy Schrecengost is Chief Scientific Officer at Targepeutics. He has 20 years of cancer research experience with more than a decade focusing on drug discovery and development. He has been with Targepeutics since 2020 and has lead orphan drug designation approval for the lead platform and successfully applied for SBIR and DOD grant funding. Randy oversees all aspects of research at Targepeutics and facilitates and manages collaborative research projects at multiple research institutions. Prior to joining Targepeutics, he was Senior Scientist at Apogee Biotechnology Company where he managed the prostate cancer research program. His work was instrumental in moving the lead compound forward into prostate cancer clinical trials. Dr Schrecengost received his PhD in Microbiology from the University of Virginia and completed a post-doctoral fellowship at Thomas Jefferson University.